Navigation Links
Pennsylvania Insurance Commissioner Testifies in Support of Pharmaceutical Price Transparency Bill to Help Control Health Insurance Costs
Date:2/8/2017

HARRISBURG, Pa., Feb. 8, 2017 /PRNewswire-USNewswire/ -- Insurance Commissioner Teresa Miller testified before the House Insurance Committee in favor of House Bill 161 (HB 161), sponsored by House Insurance Committee Democratic Chairman Tony DeLuca, which would require drug manufacturers to disclose to the Insurance Department the cost of certain drugs with higher wholesale costs and those drugs with wholesale prices that have increased rapidly.

"Rising prescription drug prices are a major reason premiums in the individual health insurance market rose significantly last year. In the individual market pharmaceutical drugs rose from 13.6 percent of per enrollee health care claims in 2014 to 21.4 percent in 2015, a 57 percent increase," Commissioner Miller told the committee. "Per enrollee pharmaceutical costs for plans sold to our small employers and their employees rose 33 percent over the same period. In order to make health insurance more affordable, we need to make the care health insurance pays for more affordable, and prescription drug prices are a huge part of that."

The National Business Group on Health, a non-profit association of 425 large employers, also cited in 2016, for the first time, specialty drugs as the highest driver of health costs. Nearly one-third, 31 percent, of respondents to the Large Employers' 2017 Health Plan Design Survey said specialty drug costs were the top driver of health costs.

HB 161 would require a prescription drug manufacturer to disclose to the Insurance Department the costs of production for drugs with average wholesale prices greater than $5,000 annually, or throughout the course of treatment. The bill would also require disclosure of production costs for drugs whose wholesale price has increased 50 percent or more over the past five years, or 25 percent or more over the past twelve months. Commissioner Miller applauded House Insurance Committee Chairs DeLuca and Tina Pickett for holding the hearing and increasing awareness of this important issue.

"The Insurance Department has no direct regulatory authority over prescription drug costs," Commissioner Miller testified. "We do have some authority to ensure drugs consumers need are covered and covered fairly, but there is currently no mechanism to look at the issue of cost.  This legislation would be an important first step in that direction."

Commissioner Miller said many issues involving the pharmaceutical industry can only be dealt with at the federal level. However, she noted the Insurance Department has taken a number of steps to increase transparency in the insurance industry, including posting health insurance rate review information on its website, and holding public hearings on health and long term care insurance rates and surprise balance billing. Commissioner Miller believes strongly that transparency is the first step to improving many aspects of our health care system and that understanding the cost drivers behind health insurance premium increases, like rising prescription drug costs, is the first step to making health insurance more affordable.  

Consumers with questions or concerns about health insurance should contact the Insurance Department's Bureau of Consumer Services, visit www.insurance.pa.gov or call 1-877-881-6388.

MEDIA CONTACT: Ron Ruman- 717-787-3289

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/pennsylvania-insurance-commissioner-testifies-in-support-of-pharmaceutical-price-transparency-bill-to-help-control-health-insurance-costs-300404355.html


'/>"/>
SOURCE Pennsylvania Insurance Department
Copyright©2017 PR Newswire.
All rights reserved


Related medicine technology :

1. Pennsylvania Physicians Urge State Legislators to Support Immunization Expansion Bill
2. Report: Upgrading Medicaid Drug Benefits Could Save Pennsylvania $896 Million
3. Wrong-Patient Medication Errors Examined by the Pennsylvania Patient Safety Authority
4. Center for Organ Recovery & Education Renews Call for Pennsylvania State Lawmakers to Support Donate Life PA Act
5. CHPA Applauds Pennsylvanias Adoption of Real-Time, Stop-Sale Technology, An Effective Tool in the Fight Against Methamphetamine
6. Pennsylvania Governor Corbett: Specialized Medical Company to Relocate Headquarters and Customer Service Center
7. Pharmacy Access Coalition Urges Pennsylvania General Assembly to Support Measure Expanding Access to Vaccines
8. Pennsylvania Department of Drug and Alcohol Programs Urges Participation in National Drug Take Back Day Events This Week
9. Highmark executive Michael Fiaschetti Appointed to Board of Pennsylvania eHealth Partnership Authority
10. Stakeholders elect ex-officio members to Board of Pennsylvania eHealth Partnership Authority
11. New Pennsylvania Hospital Opens, MEMdata Equipment Planning Utilized
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... NASHVILLE , Tenn. and DALLAS , ... and EndoStim, Inc., announced that the first patients in ... with the EndoStim device in the Lower Esophageal Sphincter ... is a minimally-invasive implantable device designed to provide long-term ... through neurostimulation. GERD affects nearly 65 million ...
(Date:4/19/2017)... 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... developing new treatments for cancer and other unmet ... previously announced underwritten public offering of 23,625,084 shares ... price of $2.00 per share, before deducting underwriting ... by Sorrento.  The net proceeds to Sorrento from ...
(Date:4/19/2017)... , April 19, 2017  New research provides evidence ... advanced Parkinson,s, according to a study released today that will ... Annual Meeting in Boston , April ... to the treatment of Parkinson,s disease, the oral drug levodopa ... life and longevity. But as the disease progresses, the effects ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... April 25, 2017 , ... ... HR decision-makers are preparing for how his administration could impact the employee benefits ... into what changes are most likely to make it through Congress. His discussion ...
(Date:4/25/2017)... NV (PRWEB) , ... April 25, 2017 , ... ... now choose a modern procedure that achieves results in a fraction of the ... in Las Vegas, NV, with Significance Dental Specialists, now offers this revolutionary treatment ...
(Date:4/25/2017)... Minneapolis MN (PRWEB) , ... April 25, 2017 , ... ... patients and recreational users to dispensaries and head shops –can’t help but be heartened ... loathing for the tell-tale cannabis odor aptly described as “skunk smell.” At last ...
(Date:4/25/2017)... ... 2017 , ... There is no better place in South Florida to undergo ... the May issue of Consumer Reports focused on heart health. , The magazine ... and after coronary bypass and aortic valve replacement procedures. , Consumer Reports rated ...
(Date:4/24/2017)... FLORIDA (PRWEB) , ... April 24, 2017 , ... ... telehealth technology yesterday, featuring Bring Your Own Device (BYOD) capabilities at Telehealth 2.0, ... LG CNS’ pre-packaged telehealth bundles, which pairs medical devices with a pre-programmed tablet ...
Breaking Medicine News(10 mins):